Cited by CrossRef (7)

  1. Swati S. Dash, Nikhil K. Khatri, Saraswathi Divyateja, Jignesh Bhate, Guruprasad K. S. Rao. Advances in neuropathic pain management: A review of real-world studies. 2024
    https://doi.org/10.4103/jcrsm.jcrsm_132_23
  2. Zhen-Rong Zhang, Yao Wu, Wen-Jing Wang, Fang-Yong Wang. The Effect of GABAergic Cells Transplantation on Allodynia and Hyperalgesia in Neuropathic Animals: A Systematic Review With Meta-Analysis. Front. Neurol. 2022;13
    https://doi.org/10.3389/fneur.2022.900436
  3. Tamara L. Rodríguez-Araya, Anna Arias, Xavier Torres, Elena Angulo, Esther Hernández, Maria Belen Busso, Luciano Polino. Feasibility, safety and preliminary efficacy of a new nutritional supplement for fibromyalgia patients: a pilot study. JPCPY 2024;15:265
    https://doi.org/10.15406/jpcpy.2024.15.00791
  4. QingHua Yin, TianHao Zou, ShuJun Sun, Dong Yang. Cell therapy for neuropathic pain. Front. Mol. Neurosci. 2023;16
    https://doi.org/10.3389/fnmol.2023.1119223
  5. Isabella G. Cozzone, Victoria L. Ortega, Courtney M. Dumont. Engineered Tools to Advance Cell Transplantation in the Nervous System Towards a Clinical Reality. Curr Transpl Rep 2024;11:222
    https://doi.org/10.1007/s40472-024-00451-7
  6. Yanbing Kao, Hanming Zhu, Yu Yang, Wenyuan Shen, Wei Song, Renjie Zhang, Yanchun Liu, Haoyun Liu, Xiaohong Kong. CREB1 Facilitates GABAergic Neural Differentiation of Human Mesenchymal Stem Cells through BRN2 for Pain Alleviation and Locomotion Recovery after Spinal Cord Injury. Cells 2023;13:67
    https://doi.org/10.3390/cells13010067
  7. Koohyar Ahmadzadeh, Shayan Roshdi Dizaji, Mahmoud Yousefifard. Lack of concordance between reporting guidelines and risk of bias assessments of preclinical studies; a call for integrated recommendations. 2023
    https://doi.org/10.1097/JS9.0000000000000475